Par Drugs and Chemicals 将来の成長
Future 基準チェック /06
We currently don't have sufficient analyst coverage to forecast growth and revenue for Par Drugs and Chemicals.
主要情報
n/a
収益成長率
n/a
EPS成長率
| Pharmaceuticals 収益成長 | 18.4% |
| 収益成長率 | n/a |
| 将来の株主資本利益率 | n/a |
| アナリストカバレッジ | None |
| 最終更新日 | n/a |
今後の成長に関する最新情報
更新なし
Recent updates
There's No Escaping Par Drugs and Chemicals Limited's (NSE:PAR) Muted Earnings Despite A 26% Share Price Rise
Oct 29
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified
Apr 16Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today
Apr 05Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?
Nov 03If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity
May 19Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?
Mar 17Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?
Oct 22Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings
Aug 11Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching
Jul 14Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?
Mar 31Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?
Mar 05Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)
Feb 06
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today
Jan 10How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?
Dec 13このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Par Drugs and Chemicals は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。
シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。
業績と収益の成長予測
| 日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
|---|---|---|---|---|---|
| 9/30/2024 | 1,041 | 183 | 145 | 172 | N/A |
| 6/30/2024 | 953 | 146 | N/A | N/A | N/A |
| 3/31/2024 | 956 | 145 | 142 | 202 | N/A |
| 12/31/2023 | 973 | 142 | N/A | N/A | N/A |
| 9/30/2023 | 962 | 127 | 140 | 227 | N/A |
| 6/30/2023 | 952 | 115 | N/A | N/A | N/A |
| 3/31/2023 | 957 | 113 | 57 | 134 | N/A |
| 12/31/2022 | 933 | 103 | N/A | N/A | N/A |
| 9/30/2022 | 873 | 106 | 32 | 76 | N/A |
| 6/30/2022 | 821 | 91 | N/A | N/A | N/A |
| 3/31/2022 | 751 | 92 | 44 | 76 | N/A |
| 12/31/2021 | 692 | 112 | N/A | N/A | N/A |
| 9/30/2021 | 686 | 112 | 4 | 67 | N/A |
| 6/30/2021 | 631 | 115 | N/A | N/A | N/A |
| 3/31/2021 | 608 | 116 | 70 | 121 | N/A |
| 12/31/2020 | 579 | 88 | N/A | N/A | N/A |
| 9/30/2020 | 550 | 83 | 102 | 120 | N/A |
| 6/30/2020 | 554 | 65 | 82 | 98 | N/A |
| 3/31/2020 | 558 | 48 | 61 | 77 | N/A |
| 12/31/2019 | 532 | 41 | N/A | N/A | N/A |
| 9/30/2019 | 506 | 20 | 12 | 17 | N/A |
| 6/30/2019 | 484 | 23 | 15 | 19 | N/A |
| 3/31/2019 | 463 | 25 | 30 | 34 | N/A |
| 3/31/2018 | 424 | 15 | N/A | 46 | N/A |
| 3/31/2017 | 488 | 18 | N/A | 92 | N/A |
| 3/31/2016 | 333 | 4 | N/A | 65 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: Insufficient data to determine if PAR's forecast earnings growth is above the savings rate (6.7%).
収益対市場: Insufficient data to determine if PAR's earnings are forecast to grow faster than the Indian market
高成長収益: Insufficient data to determine if PAR's earnings are expected to grow significantly over the next 3 years.
収益対市場: Insufficient data to determine if PAR's revenue is forecast to grow faster than the Indian market.
高い収益成長: Insufficient data to determine if PAR's revenue is forecast to grow faster than 20% per year.
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: Insufficient data to determine if PAR's Return on Equity is forecast to be high in 3 years time